Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma

Von Cheong, E. and Ho, Gwo Fuang (2021) Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma. Clinical Case Reports, 9 (4). pp. 2264-2268. ISSN 2050-0904, DOI https://doi.org/10.1002/ccr3.4009.

Full text not available from this repository.

Abstract

The development of resistance to trastuzumab in HER2-positive gastroesophageal cancer remains a problem. The use of dual HER2 blockade to overcome this is a therapeutic strategy that should be researched more extensively.

Item Type: Article
Funders: UNSPECIFIED
Uncontrolled Keywords: Dual HER2; Gastroesophageal cancer; HER2; Lapatinib; Trastuzumab
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Medicine > Clinical Oncology Department
Faculty of Medicine > Medicine Department
Depositing User: Ms Zaharah Ramly
Date Deposited: 23 May 2022 08:02
Last Modified: 23 May 2022 08:02
URI: http://eprints.um.edu.my/id/eprint/34953

Actions (login required)

View Item View Item